United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com

United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com

Business Wire

Published

DUBLIN--(BUSINESS WIRE)--The "U.S. Pet Medication Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The U.S. Pet Medication Market was valued at USD 13.21 billion in 2023, and is projected to reach USD 17.90 billion by 2029, showcasing a CAGR of 5.19%. The U.S. pet medication market report contains exclusive data on 39 vendors. The competition in the U.S. pet medication market is intense, with several global players offering diverse products. Curre

Full Article